which is remarkable given that it once said it viewed health as second only to financial services market as a market opportunity. IBM said it "remains committed to Watson, our broader AI business ...

AI’s impact is often seen through the lens of job displacement. This article by Kirill Yurovskiy examines How Artificial ...

IBM is busy applying its Watson AI to as many health arenas as possible and it looks like cancer genomic sequencing could be its next big market. In a new proof-of-concept study testing a beta ...

Similarly, with IBM Watson Health, AI systems analyze medical images for early disease detection. Again, AI agents shouldn’t be seen as taking human jobs. Instead, they are equipping human ...

From personalized chatbots to speech recognition systems, AI is fundamentally altering how we interact with both machines and ...

Scientific literature has increased at a rate of 8-9% annually since 1980, doubling every decade and creating an information ...

In January 2024, the IBM Watson Health AI-powered digital biomarker platform was approved by the FDA for continuous analysis of wearable device data and providing real-time biomarkers of ...

By examining patterns in comprehensive datasets, such as medical histories, genetic profiles, lifestyle information and real-time health ... Similarly, IBM Watson’s Oncology AI has achieved ...

Larger models can pull off a wider variety of feats, but the reduced footprint of smaller models makes them attractive tools.

Countless companies stand to benefit from AI, but these stocks have AI and automation as a central part of their businesses.